CRINETICS PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 42.12 USD | -0.40% |
|
-1.98% | +18.38% |
Chart calendar Crinetics Pharmaceuticals, Inc.
d1a2826f72a1fa1f35fad.dOGJIYCNahkgRsTCPUaWOsTuI0682ynBO3q5LARXRnk.FYjiebTOR2FMDaz7URfUCvKLRAHlt1ijfjDDWDAwDTo91_9V5OMdfmQ2iQ~31be217b959214e183dcbf351dec6ad0
Upcoming events on Crinetics Pharmaceuticals, Inc.
Past events on Crinetics Pharmaceuticals, Inc.
| 19/03/2024 06:00 pm | PATHFNDR 2 Phase 3 Study Results Call |
| 13/03/2024 02:00 am | Paltusotine Phase 2 Study Results Call |
| 29/02/2024 03:00 am | Q4 2023 Earnings Call |
| 29/02/2024 02:35 am | Q4 2023 Earnings Release |
| 10/01/2024 05:15 am | JPMorgan Healthcare Conference |
| 19/12/2023 03:30 am | Business Update Call |
| 30/11/2023 06:30 pm | Piper Sandler Healthcare Conference |
| 29/11/2023 02:20 am | Evercore ISI HealthCONx Conference |
| 08/11/2023 02:35 am | Q3 2023 Earnings Release |
| 26/09/2023 10:30 pm | Cantor Global Healthcare Conference |
| 11/09/2023 05:30 pm | Paltusotine PATHFNDR-1 Phase 3 Study Results Call |
| 08/08/2023 09:30 pm | Investor Meeting - Key Opinion Leader |
| 08/08/2023 04:30 pm | Q2 2023 Earnings Release |
| 18/06/2023 06:30 pm | Endocrine Society Meeting - Oral Session OR30 |
| 17/06/2023 11:30 pm | Endocrine Society Meeting - Poster SAT-182 |
| 17/06/2023 11:30 pm | Endocrine Society Meeting - Poster SAT-628 |
| 16/06/2023 10:30 pm | Endocrine Society Meeting - Poster FRI-546 |
| 16/06/2023 | Annual General Meeting |
| 15/06/2023 08:30 pm | Endocrine Society Meeting - Oral Session OR01 |
| 13/06/2023 09:30 am | H.C. Wainwright Emerging Ideas in Biopharma |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1,19 1,03 15.68% | 0,07 0,09 -19.68% | 1,08 0,00 - | 4,74 4,32 9.73% | 4,01 4,21 -4.73% | 1,50 |
|
EBITDA Million USD | Released Forecast Spread | -52,9 -53,7 1.42% | -74,0 -68,7 -7.67% | -107 -106 -0.38% | -167 -167 0.04% | -222 -220 -0.58% | -263 |
|
EBIT Million USD | Released Forecast Spread | -53,8 -55,4 2.76% | -75,0 -73,4 -2.18% | -108 -106 -1.96% | -168 -166 -1.3% | -223 -216 -2.92% | -259 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -50,4 -52,3 3.52% | -73,8 -72,4 -1.88% | -108 -105 -2.07% | -164 -164 -0.22% | -209 -207 -1.34% | -241 |
|
Net income Million USD | Released Forecast Spread | -50,4 -52,2 3.41% | -73,8 -71,7 -2.96% | -108 -105 -2.74% | -164 -163 -0.59% | -215 -209 -2.77% | -243 |
|
EPS USD | Released Forecast Spread | -2,09 -2,16 3.36% | -2,42 -2,35 -2.93% | -2,80 -2,70 -3.64% | -3,15 -3,22 2.3% | -3,69 -3,58 -3.06% | -3,30 |
| Announcement Date | 09/03/20 | 30/03/21 | 30/03/22 | 28/02/23 | 28/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1,08 0,00 - | 3,13 5,20 -39.79% | 0,44 0,72 -39.03% | 0,46 0,20 129% | 0,71 0,30 136.33% | 2,68 0,24 997.32% | 0,99 1,28 -22.8% | 0,35 0,14 145.15% | 0,00 0,18 - | 0,10 | 0,60 | 0,10 | 0,60 | 0,03 |
|
EBITDA Million USD | Released Forecast Spread | -30,7 -30,0 -2.18% | -33,6 -21,0 -59.94% | -42,8 -37,0 -15.76% | -43,2 -44,0 1.8% | -47,3 -47,0 -0.59% | -47,7 -49,0 2.66% | -62,4 -60,0 -3.99% | -60,1 | -62,7 | -65,8 | -69,4 | |||
|
EBIT Million USD | Released Forecast Spread | -30,9 -29,4 -5.23% | -33,8 -28,0 -20.79% | -43,0 -35,6 -21% | -43,5 -44,6 2.47% | -47,6 -45,5 -4.5% | -48,0 -48,4 0.85% | -53,0 -47,5 -11.54% | -59,0 -51,0 -15.65% | -62,7 -55,1 -13.77% | -62,4 | -64,5 | -67,0 | -69,0 | -68,1 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -30,8 -29,2 -5.49% | -34,6 -27,8 -24.45% | -42,4 -34,5 -22.71% | -41,9 -43,7 4% | -45,0 -45,3 0.63% | -46,0 -47,5 3.11% | -51,0 -46,4 -9.88% | -57,5 -48,0 -19.59% | -55,9 -54,0 -3.46% | -57,8 | -60,0 | -62,5 | -64,6 | -65,0 |
|
Net income Million USD | Released Forecast Spread | -30,8 -28,2 -9.31% | -34,6 -28,1 -23.26% | -42,4 -34,0 -24.45% | -41,9 -42,6 1.54% | -45,0 -44,1 -1.95% | -46,0 -47,0 2.13% | -51,0 -47,5 -7.22% | -57,5 -49,3 -16.44% | -60,1 -54,8 -9.66% | -59,0 | -60,4 | -62,7 | -64,8 | -65,0 |
|
EPS USD | Released Forecast Spread | -0,68 -0,60 -12.96% | -0,73 -0,56 -29.55% | -0,81 -0,66 -23.51% | -0,78 -0,81 4% | -0,84 -0,83 -1.82% | -0,85 -0,84 -1.46% | -0,94 -0,86 -9.67% | -1,01 -0,86 -17.44% | -0,90 -0,88 -2.85% | -0,80 | -0,79 | -0,83 | -0,85 | -0,91 |
| Announcement Date | 30/03/22 | 12/05/22 | 12/08/22 | 14/11/22 | 28/02/23 | 04/05/23 | 08/08/23 | 07/11/23 | 28/02/24 | - | - | - | - | - |
More events
Past sector events for Crinetics Pharmaceuticals, Inc.
| 27/04/2024 | GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release |
| 27/04/2024 | GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 26/04/2024 10:30 am | BB BIOTECH AG: Q1 2024 Earnings Release |
| 26/04/2024 | BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 26/04/2024 | PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release |
| 26/04/2024 | HINOVA PHARMACEUTICALS INC.: Q1 2024 Earnings Release (Projected) |
| 26/04/2024 | BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q4 2023 Earnings Release |
| 26/04/2024 | CHEMPARTNER PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 25/04/2024 04:30 pm | MORPHIC HOLDING, INC.: Q1 2024 Earnings Release |
| 25/04/2024 11:30 am | PURETECH HEALTH PLC: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- CRNX Stock
- Calendar Crinetics Pharmaceuticals, Inc.
